Semaglutide, available as Ozempic for type 2 diabetes and Wegovy for chronic weight management, and tirzepatide, marketed as Mounjaro for type 2 diabetes and Zepbound for weight management, are prominent examples of FDA-approved GLP-1 receptor agonists (Kommu S et al., 2025
Clinical research supports the use of glutathione therapy in liver disease
Lipid peroxidation and ferroptosis: The role of GSH and GPx4
2) Focus on signals, not the scale Pay attention to appetite, fullness, and eating patternsthese often shift before visible results return
Moreover, G49 increased Cpt1b gene expression and FAO and up-regulated lipolysis, thermogenic gene expression ( Ucp1, Ppargc1a, Sir2 ) and UCP1 protein levels in BA (Fig